Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 12, 2014, Pages 1966-1974

  Blackshear, J L ^a   Wysokinska, E M ^b   Safford, R E ^a   Thomas, C S ^a   Shapiro, B P ^a   Ung, S ^a   Stark, M E ^a   Parikh, P ^a   Johns, G S ^a   Chen, D ^c  

^a MAYO CLINIC   (United States)

^b Willmar Cancer Center   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Gastrointestinal hemorrhage; Hemorrhage; Mitral valve insufficiency; Von Willebrand diseases; Von Willebrand factor

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIODYSPLASIA; ARTICLE; BLOOD TRANSFUSION; ECHOCARDIOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; PROSPECTIVE STUDY; PROTEIN FUNCTION; SHEAR STRESS; THROMBOCYTE FUNCTION ANALYZER; VON WILLEBRAND DISEASE; CHEMISTRY; COMORBIDITY; COMPLICATION; FEMALE; HEMOSTASIS; MALE; MECHANICAL STRESS; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MOLECULAR WEIGHT; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; SHEAR STRENGTH; VERY ELDERLY; VON WILLEBRAND DISEASES;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MOLECULAR WEIGHT; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SHEAR STRENGTH; STRESS, MECHANICAL; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84916641644     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12734     Document Type: Article

References (36)

1. Loscalzo J. From clinical observation to mechanism - Heyde's syndrome. N Engl J Med 2012; 367: 1954-6.
2. Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V III, Sharma R, Wu J, Arepelly G, Bowles D, Rogers J, Villamizar-Ortiz N. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010; 90: 1263-9.
3. Eckman PM, John R. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 2012; 125: 3038-47.
4. Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Trummer G, Berchtold-Hertz M, Schlensak C, Zieger B. Acquired von Willebrand syndrome is an early-onset problem in ventricular assist device patients. Eur J Cardiothorac Surg 2011; 40: 1328-33.
5. Blackshear JL, Wysokinska EM, Safford RE, Thomas CS, Stark ME, Shapiro BP, Ung S, Johns GS, Chen D. Indexes of von Willebrand factor as biomarkers of aortic stenosis severity: (From the Biomarkers of Aortic Stenosis Severity BASS Study). Am J Cardiol 2013; 111: 374-81.
6. Demirozu AT, Radovancevic R, Hochman LF. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011; 30: 849-53.
7. Aggarwal A, Pant F, Kumar S, Sharma P, Gallagher C, Tatooles C, Pappas CS, Bhat G. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 2012; 93: 1534-40.
8. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 2000; 84: 345-9.
9. Tarnow I, Kristensen AT, Olsen LH, Falk T, Haubro L, Pedersen JG, Pedersen HD. Dogs with heart diseases causing turbulent high-velocity blood flow have changes in platelet function and von Willebrand factor multimer distribution. J Vet Intern Med 2005; 19: 515-22.
10. Budde U, Bergmann F, Michiels JJ. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Semin Thromb Hemost 2002; 28: 227-38.
11. Froom P, Margulis T, Granadier E, Palant A, David M, Aghai E. von Willebrand factor and mitral valve prolapse. Thromb Haemost 1988; 60: 230-1.
12. Weinstein M, Ware JA, Troll J, Salzman E. Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood 1988; 71: 1648-55.
13. Pappalardo F, Della Valle P, Maj G, Franco A, Lattuada A, Ladnoi G, Zangrillo A, D'Angelo A. Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair.HSR Proc Intensive Care Cardiovasc Anesth 2010; 2: 119-27.
14. Pickering NJ, Brody JI, Barrett MJ. von Willebrand syndromes and mitral-valve prolapse - linked mesenchymal dysplasia. N Engl J Med 1981; 305: 131-4.
15. Perez-Rodriguez A, Pinto JC, Loures E, Rodriguez-Trillo A, Cuenca JJ, Batlle J, Lopez-Fernandez MF. Acquired von Willebrand syndrome and mitral valve prosthesis leakage. A pilot study. Eur J Haematol 2011; 87: 448-56.
16. Pizarro R, Bazzino OO, Oberti PF, Falconi M, Achilli F, Arias A, Krauss JG, Cagide AM. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol 2009; 54: 1099-106.
17. Yoshida K, Tobe S, Kawata M, Yamaguchi M. Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. Ann Thorac Surg 2006; 81: 490-4.
18. Casonato A, Sponga S, Pontara E. von Willebrand factor abnormalities in aortic valve stenosis: pathophysiology and impact on bleeding. Thromb Haemost 2011; 106: 58-66.
19. Solomon C, Budde U, Shcneppenheim S. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery. Br J Anesth 2011; 106: 494-500.
20. Sucker C, Feindtz P, Zotzi RB, Stockschlaeder M, Scharf RE. Functional von Willebrand factor assays are not predictive for the absence of highest-molecular weight von Willebrand factor multimers in patients with aortic-valve stenosis. Thromb Haemost 2005; 94: 465-6.
21. Joyce D, Crow S, Zhuo L, Joyce L, Milano C, Rogers J, Villamizar-Ortiz N, Chen D. Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients. J Heart Lung Transplant 2012; 31: 750-6.
22. Thompson JL, Schaff HV, Dearani JA, Park SJ, Sundt TM, Suri R, Blackshear JL, Daly RC. Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome. J Thorac Cardiovasc Surg 2012; 144: 112-16.
23. Lenting PJ, Casari C, Christophe OD, Denis CV. von Willebrand factor: the old, the new, and the unknown. J Thromb Haemost 2012; 10: 2428-37.
24. Franchini M, Mannucci PM. von Willebrand disease-associated angiodysplasia: a few answers, still many questions. Br J Haematol 2013; 161: 177-82.
25. Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TAJ, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011; 117: 1071-80.
26. Le Tourneau TL, Susen S, Caron C, Millaire S, Ennezat PV, Lamblin N, de Groote P, van Belle E, Marechaux BJ, Polge A-S, Vincentelli A, Mouquet F, Ennezat P-V, Lamblin N, de Groote P, van Belle E, Deklunder G, Goudemand J, Bauters C, Jude B. . Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction. Circulation 2008; 118: 1550-7.
27. Blackshear JL, Schaff HV, Ommen SR, Chen D, Nichols WL. Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willbrand syndrome: response to septal myectomy. Mayo Clinc Proc 2011; 86: 219-24.
28. Gillinov AM. Ablation of atrial fibrillation with mitral valve surgery. Curr Opin Cardiol 2005; 20: 107-14.
29. Zoghbi WA, Enrique-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine FA, Nihoyannopolous P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
30. Biner S, Rafique A, Raifi F, Tolstrup K, Noorani O, Shiota T, Gurudevan S, Siegel RJ. Reproducibility of proximal isovelocity surface area, vena contracta, and regurgitant jet area for assessment of mitral regurgitation severity. JACC Cardiovasc Imaging 2010; 3: 235-43.
31. Thomas N, Unsworth B, Ferenczi EA, Davies JE, Mayet J, Francis DP. Intraobserver variability in grading severity of repeated identical cases of mitral regurgitation. Am Heart J 2008; 156: 1089-94.
32. Schiller N. Color Me Variable: the irreproducible nature of color flow Doppler in mitral and aortic regurgitation. Am Heart J 2002; 44: 5-7.
33. Grayburn PA, Bhella P. Grading severity of mitral regurgitation by echocardiography: science or art? JACC Cardiovasc Imaging 2010; 3: 244-6.
34. Avierinos JF, Detaint D, Messika-Zeitoun D, Mohty D, Enriquez-Sarano M. Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community. Am J Cardiol 2008; 101: 662-7.
35. Enriquez-Sarano M, Basmadjian AJ, Rossi A, Bailey KR, Seward JB, Tajik AJ. Progression of mitral regurgitation. J Am Coll Cardiol 1999; 34: 1137-44.
36. Gertz ZM, Raina A, Saghy L, Zado ES, Callans DJ, Marchlinski FE, Keane MG, Silvestry FE. Evidence of atrial functional mitral regurgitation due to atrial fibrillation - reversal with arrhythmia control. J Am Coll Cardiol 2011; 58: 1474-81.